Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Aug 15, 2026; 18(8): 122077
Published online Aug 15, 2026. doi: 10.4251/wjgo.122077
Published online Aug 15, 2026. doi: 10.4251/wjgo.122077
Table 3 The distribution of lymph nodes according to different T stages, n (%)
| Variables | Staining (n = 137) | Non-staining (n = 137) | P value |
| T1 patients (n = 40) | 733 | 27 | < 0.001a |
| Non-metastatic LNs | 728 (99.3) | 26 (79.7) | |
| Metastatic LNs | 5 (0.7) | 1 (14.2) | |
| T2 patients (n = 26) | 462 | 43 | < 0.001a |
| Non-metastatic LNs | 456 (98.7) | 28 (65.1) | |
| Metastatic LNs | 6 (1.3) | 15 (34.9) | |
| T3 patients (n = 61) | 1272 | 281 | < 0.001a |
| Non-metastatic LNs | 1226 (96.4) | 257 (91.5) | |
| Metastatic LNs | 46 (3.6) | 24 (8.5) | |
| T4 patients (n = 10) | 182 | 49 | < 0.001a |
| Non-metastatic LNs | 177 (97.3) | 37 (75.5) | |
| Metastatic LNs | 5 (2.7) | 12 (24.5) |
- Citation: Bai BJ, Xu DY, Chen L, Ding LY, Song ZF. Clinical value of carbon nanoparticles in identifying metastatic lymph nodes in colorectal cancer: A single-center observational study. World J Gastrointest Oncol 2026; 18(8): 122077
- URL: https://www.wjgnet.com/1948-5204/full/v18/i8/122077.htm
- DOI: https://dx.doi.org/10.4251/wjgo.122077